Seigla Medical, Inc.

Seigla Medical manufactures the liquID® Guide Catheter Extension, a specialized interventional cardiology device designed for percutaneous coronary intervention (PCI) procedures. The product features an 18% larger lumen and 45% thinner wall (0.0030″ vs. 0.0050″) compared to conventional guide catheters, enabling physicians to navigate complex coronary anatomy with improved access and reduced trauma. The liquID® is available in radial-access-compatible 6Fr and 7Fr configurations, supporting both femoral and radial vascular access approaches without requiring access conversion. The company holds ISO 13485:2016 certification under the MDSAP framework and maintains CE marking in Europe. Products are distributed internationally through a global network of medical device distributors. Seigla Medical serves interventional cardiologists and cardiac catheterization laboratories in both US and international markets.